Benitec Biopharma (BNTC) Other Accumulated Expenses (2019 - 2025)
Benitec Biopharma (BNTC) reported Other Accumulated Expenses of $62000.0 for Q4 2025, down 32.61% on a YoY basis from $92000.0 in Q4 2024, and down 57.82% sequentially from $147000.0 in Q3 2025.
Benitec Biopharma (BNTC) Other Accumulated Expenses (2019 - 2025) Analysis & Trends
Benitec Biopharma (BNTC) has 7 years of Other Accumulated Expenses data on file, last reported at $62000.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Accumulated Expenses fell 32.61% year-over-year to $62000.0; the trailing twelve-month figure through Dec 2025 stood at $62000.0 (down 32.61% YoY), and the FY2025 full-year result was $67000.0, down 51.45% from the prior year.
- Other Accumulated Expenses declined to $62000.0 in Q4 2025, from $147000.0 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $223000.0 in Q4 2021 to a low of $36000.0 in Q1 2023.
- A 5-year average of $96050.0 and a median of $76500.0 in 2023 frame the typical range for Other Accumulated Expenses.
- Across the five-year window, Other Accumulated Expenses plunged 81.61% in 2022 and jumped 149.15% in 2025, its largest moves.
- Tracing BNTC's Other Accumulated Expenses over 5 years: stood at $223000.0 in 2021, then sank by 81.61% to $41000.0 in 2022, then jumped by 80.49% to $74000.0 in 2023, then advanced by 24.32% to $92000.0 in 2024, then sank by 32.61% to $62000.0 in 2025.
- Business Quant data shows BNTC's Other Accumulated Expenses at $62000.0 in Q4 2025, $147000.0 in Q3 2025, and $67000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Benitec Biopharma | 46.45 Mn | 46.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 62,000.00 |
| Sep 30, 2025 | 147,000.00 |
| Jun 30, 2025 | 67,000.00 |
| Mar 31, 2025 | 157,000.00 |
| Dec 31, 2024 | 92,000.00 |
| Sep 30, 2024 | 59,000.00 |
| Jun 30, 2024 | 138,000.00 |
| Mar 31, 2024 | 79,000.00 |
| Dec 31, 2023 | 74,000.00 |
| Sep 30, 2023 | 40,000.00 |
| Jun 30, 2023 | 69,000.00 |
| Mar 31, 2023 | 36,000.00 |
| Dec 31, 2022 | 41,000.00 |
| Sep 30, 2022 | 128,000.00 |
| Jun 30, 2022 | 71,000.00 |
| Mar 31, 2022 | 56,000.00 |
| Dec 31, 2021 | 223,000.00 |
| Sep 30, 2021 | 86,000.00 |
| Jun 30, 2021 | 115,000.00 |
| Mar 31, 2021 | 181,000.00 |